A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2011
08/09/2011	CA2634664C Novel albumin-free factor viii formulations
08/09/2011	CA2625554C Enteric soft capsule comprising valproic acid
08/09/2011	CA2568640C Pharmaceutical composition containing irbesartan
08/09/2011	CA2518918C Alpha-hydroxy acid ester drug delivery compositions and methods of use
08/09/2011	CA2508281C Method for producing sterile polynucleotide based medicaments
08/09/2011	CA2500712C Antibiotic pharmaceutical composition with improved oral absorbability
08/09/2011	CA2474645C Compositions and methods for systemic inhibition of cartilage degradation
08/09/2011	CA2451377C Oral pharmaceutical compositions with improved bioavailability
08/09/2011	CA2448927C Pharmaceutical composition
08/09/2011	CA2434484C Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances
08/09/2011	CA2243559C Pharmaceutical composition for immunomodulation
08/04/2011	WO2011094613A1 Dental strip for administration of oral treatment
08/04/2011	WO2011094608A2 Two-wrist data gathering system
08/04/2011	WO2011094531A1 Solid pharmaceutical composition with enhancers and methods of preparing thereof
08/04/2011	WO2011094491A1 Compositions comprising sugar-cysteine products
08/04/2011	WO2011094431A1 Sustained-release nsaid/hmg coa reductase inhibitor compositions
08/04/2011	WO2011094352A1 In-vivo non-viral gene delivery of human vascular endothelial growth factor following islet transplantation
08/04/2011	WO2011094023A1 Extruded animal litters having an increased absorption rate
08/04/2011	WO2011093833A2 Effervescent formulations comprising second generation cephalosporin
08/04/2011	WO2011093832A2 Stable efervescent formulations comprising cefaclor
08/04/2011	WO2011093831A2 Effervescent formulations comprising cefprozil as active agent
08/04/2011	WO2011093829A1 Effervescent formulations comprising cefixime and clavulanic acid as active agents
08/04/2011	WO2011093828A2 Solid dosage forms comprising cefprozil
08/04/2011	WO2011093827A1 Water dispersible cefdinir and clavulanic acid formulations for treatment of bacterial infections
08/04/2011	WO2011093826A2 Effervescent formulations comprising cefaclor and clavulanic acid as active agents
08/04/2011	WO2011093825A2 Effervescent dosage forms comprising cephalosporin antibiotic
08/04/2011	WO2011093824A2 Effervescent formulations comprising cefaclor
08/04/2011	WO2011093823A2 Effervescent formulations comprising cefaclor and clavulanic acid
08/04/2011	WO2011093822A1 Effervescent formulations comprising cefixime and clavulanic acid as active agents
08/04/2011	WO2011093821A1 Effervescent formulations comprising cefdinir and clavulanic acid
08/04/2011	WO2011093820A2 A pharmaceutical combination comprising tiotropium
08/04/2011	WO2011093819A2 New combination comprising tiotropium
08/04/2011	WO2011093818A2 Pharmaceutical compositions comprising salmeterol and fluticasone
08/04/2011	WO2011093817A1 Pharmaceutical compositions comprising tiotropium, formoterol and budesonide
08/04/2011	WO2011093816A1 Dry powder formulation comprising a pharmaceutical combination of tiotropium bromide, formoterol fumarate and mometasone furoate
08/04/2011	WO2011093815A2 Pharmaceutical compositions comprising formoterol and mometasone
08/04/2011	WO2011093814A2 A pharmaceutical combination comprising formoterol and ciclesonide
08/04/2011	WO2011093813A1 Dry powder pharmaceutical composition comprising tiotropium and fluticasone
08/04/2011	WO2011093812A2 Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form
08/04/2011	WO2011093811A2 Pharmaceutical preparations comprising formoterol and fluticasone
08/04/2011	WO2011093810A2 Dry powder pharmaceutical composition comprising tiotropium and mometasone
08/04/2011	WO2011093809A2 Dry powder pharmaceutical composition comprising tiotropium and ciclesonide
08/04/2011	WO2011093612A2 Oral complex composition comprising pseudoephedrine and levocetirizine
08/04/2011	WO2011093535A1 Matrix pharmaceutical composition containing galantamine
08/04/2011	WO2011093498A1 Loxoprofen-containing pharmaceutical composition
08/04/2011	WO2011093416A1 Pharmaceutical composition and preparation for oral administration
08/04/2011	WO2011093083A1 Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor
08/04/2011	WO2011093081A1 Injectable solution containing therapeutic agent for osteoarthritis
08/04/2011	WO2011092690A1 Compositions and methods for prevention and treatment of pulmonary hypertension
08/04/2011	WO2011092537A1 Composition and method for treating ulcers
08/04/2011	WO2011092511A1 Propolis and process for the treatment thereof and end products formed therefrom.
08/04/2011	WO2011092231A1 Cytokines for the treatment of addictions
08/04/2011	WO2011091816A1 Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
08/04/2011	WO2011091719A1 Crystalline hydrates of alkyl acyl acetaldehyde sulfite, preparation methods and uses thereof
08/04/2011	WO2011071877A3 Partial dip coating of dosage forms for modified release
08/04/2011	WO2011067669A3 Hydrophilic filtration during manufacture of vaccine adjuvants
08/04/2011	WO2011031621A3 High strength seamless alginate capsules
08/04/2011	WO2011005381A3 Vortex-induced silk fibroin gelation for encapsulation and delivery
08/04/2011	WO2010061386A3 Pharmaceutical composition and system for permeabilizing fetal membranes
08/04/2011	US20110190722 Compositions for use as or in wound dressings
08/04/2011	US20110190688 Permeant Delivery System and Methods for Use Thereof
08/04/2011	US20110190623 Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy
08/04/2011	US20110190604 Nitric oxide sensors and systems
08/04/2011	US20110190566 Polymer microgel beads
08/04/2011	US20110190387 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
08/04/2011	US20110190238 Modifications of solid 3-sn-phosphoglycerides
08/04/2011	US20110190219 Treating cancer with granulocyte-macrophage colony stimulating factor
08/04/2011	US20110190203 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers
08/04/2011	US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/04/2011	US20110189300 siRNA SILENCING OF APOLIPOPROTEIN B
08/04/2011	US20110189299 Pharmaceutical composition containing surface-coated microparticles
08/04/2011	US20110189298 Double emulsion and method to produce such
08/04/2011	US20110189297 Stable solid oral dosage co-formulations
08/04/2011	US20110189296 Bone substitute containing porous bio-glass and calcium sulphate
08/04/2011	US20110189295 Telmisartan tablets
08/04/2011	US20110189293 Therapeutic regimens for the treatment of immunoinflammatory disorders
08/04/2011	US20110189292 Dermal fillers comprising silk fibroin hydrogels and uses thereof
08/04/2011	US20110189291 Dendrimer hydrogels
08/04/2011	US20110189290 Compositions Comprising Capture Peptides for A B-Amyloid Peptide
08/04/2011	US20110189289 Cell-Based Method and Means for Rebuilding Bone
08/04/2011	US20110189287 Methods and compositions for wound healing
08/04/2011	US20110189286 Pulsatile Release of Valsartan
08/04/2011	US20110189285 Hydrogel capable of containing and conveying cells
08/04/2011	US20110189284 Peptide Fibres
08/04/2011	US20110189283 Appetising medicaments for oral administration in solid form for prevention and/or treatment of cardiac insufficiency in animals
08/04/2011	US20110189282 Tablet
08/04/2011	US20110189281 Telmisartan and hydrochlorothiazide combination therapy
08/04/2011	US20110189280 Dosage form comprising 1-isopropyl-4-hexahydro-1h-1,4-diazepine or a salt thereof
08/04/2011	US20110189279 Pharmaceutical compositions with modified release properties comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid
08/04/2011	US20110189278 Pterostilbene cocrystals
08/04/2011	US20110189277 Pterostilbene cocrystals
08/04/2011	US20110189276 Pterostilbene cocrystals
08/04/2011	US20110189275 Pterostilbene cocrystals
08/04/2011	US20110189274 Stable Pharmaceutical Compositions Of Montelukast Or Its Salts Or Solvates Or Hydrates
08/04/2011	US20110189273 Amantadine compositions and methods of use
08/04/2011	US20110189272 Pharmaceutical preparation containing gabapentin
08/04/2011	US20110189271 Pharmaceutical formulations of acid-labile drugs
08/04/2011	US20110189270 Differential Loading Of Drug-Eluting Medical Devices
08/04/2011	US20110189269 Extended release composition containing tramadol
08/04/2011	US20110189268 Inhibition of Placenta Growth Factor (PLGF) Mediated Metastasis and/or Angiogenesis

1 ... 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 ... 2991